Lilly beats estimates with solid Q2 performance
July 26, 2013Sales and Marketing Q2, cymbalta, lilly, zyprexa
Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …
Teva and Lonza abandon biosimilars joint venture
July 26, 2013Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars
Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …
Two non-executive directors join NICE Board
July 26, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NICE, finbarr martin, mumford
The Department of Health has announced that two new non-executive directors will join the National Institute for Health and Care …
Strong growth for Roche in latest results
July 25, 2013Sales and Marketing Alexion, Q2, Rituxan, Roche
Roche has seen strong sales growth in the past six months as it lines up new products to replace its …
UK rejects meningitis B vaccine Bexsero
July 25, 2013Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b
The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …
Actions in China ‘shameful’ says GSK boss
July 25, 2013Medical Communications, Sales and Marketing China, GSK, Witty, bribery
GlaxoSmithKline has admitted that allegations of corruption at its China business are ‘shameful’ and will seek out its cause. Speaking …
Chiltern hires Andrew Monaghan as director
July 25, 2013Manufacturing and Production, Research and Development, Sales and Marketing CRO, chiltern, monaghan
Contract research organisation Chiltern has appointed Andrew Monaghan as its director of Global Pharmacovigilance. Monaghan has more than 30 years’ …
Benlysta once again rejected by NICE
July 25, 2013Sales and Marketing Benlysta, GSK, NHS, NICE
NICE has opened a second public consultation for GSK’s lupus drug Benlysta after the Institute has again rejected the medicine …
AMRI says troubled Burlington plant back on track
July 24, 2013Manufacturing and Production AMRI, FDA, GMP
It looks like contract research and manufacturing organisation AMRI can put the quality problems at its facility in Burlington behind …
GSK sales up – impact of China allegations to follow
July 24, 2013Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency
GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …
Transition Therapeutics buys into Lilly bone drug
July 24, 2013Research and Development, Sales and Marketing Transition, bone, lilly
Transition Therapeutics has bought Lilly’s early-stage osteoarthritis drug TT-601 that is designed to help patients with chronic bone pain. Transition …
New Roche leukaemia drug beats rival
July 24, 2013Research and Development, Sales and Marketing Rituxan, Roche, leukaemia, obinutuzumab
Roche’s next generation leukaemia drug obinutuzumab has beaten the firm’s ageing blood cancer medicine Rituxan in a late-stage trial. The …
Pharma groups want limited data release
July 24, 2013Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency
The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …
Professor Trevor Jones CBE appointed chairman of Simbec Research
July 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing ABPI, simbec, trevor jones
Clinical research organisation Simbec Research has appointed Professor Trevor Jones CBE as non-executive chairman of the Board of directors. Jones …
AstraZeneca staff questioned in China
July 23, 2013Medical Communications, Sales and Marketing AstraZeneca, China, GSK, bribery
AstraZeneca says it has no details on the reasons why three of its employees in China have been questioned by …
MSD cleared by PMCPA
July 23, 2013Medical Communications, Sales and Marketing ABPI, MSD, Merck, PMCPA, code
Merck Sharp Dohme has been found not guilty of breaching two clauses in the ABPI Code of Practice – including …
FDA warning letter for troubled Wockhardt plant
July 23, 2013Manufacturing and Production FDA, Wockhardt, warning
The US regulator has issued a warning letter to a facility operated by Indian drugmaker Wockhardt already subject to an …
Pharma manufacturing news in brief
July 23, 2013Manufacturing and Production Fujifilm, Molecular Profiles, Penn Pharma, Rafarma, Riboxx Pharma, United Arab Emirates
UAE ‘s bid to boost domestic drug industry plus facility updates from Penn Pharma and Molecular Profiles head our round-up …
Strategic North hires Rosalyn Bilton as consultant
July 23, 2013Medical Communications, Research and Development, Sales and Marketing Strategic North, bilton
Healthcare agency Strategic North has welcomed its latest recruit Rosalyn Bilton to the team in the role of consultant. Bilton …
NICE ‘no’ for MabThera
July 23, 2013Sales and Marketing MabThera, NHS, NICE, Roche
Roche has been dealt a blow by NICE, with the health watchdog deciding that MabThera should not be used on …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
